Cheung NK - Search Results

1

Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma.

Daghighian F, Pentlow KS, Larson SM, Graham MC, DiResta GR, Yeh SD, Macapinlac H, Finn RD, Arbit E, Cheung NK. Daghighian F, et al. Among authors: cheung nk. Eur J Nucl Med. 1993 May;20(5):402-9. doi: 10.1007/BF00208998. Eur J Nucl Med. 1993. PMID: 8519259

2

Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities.

Yeh SD, Larson SM, Burch L, Kushner BH, Laquaglia M, Finn R, Cheung NK. Yeh SD, et al. Among authors: cheung nk. J Nucl Med. 1991 May;32(5):769-76. J Nucl Med. 1991. PMID: 1902508 Free article.

3

Technical challenges associated with the radiolabeling of monoclonal antibodies utilizing short-lived, positron emitting radionuclides.

Finn R, Cheung NK, Divgi C, St Germain J, Graham M, Pentlow K, Larson SM. Finn R, et al. Among authors: cheung nk. Int J Rad Appl Instrum B. 1991;18(1):9-13. doi: 10.1016/0883-2897(91)90040-r. Int J Rad Appl Instrum B. 1991. PMID: 2010313 Review.

4

Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors.

Arbit E, Cheung NK, Yeh SD, Daghighian F, Zhang JJ, Cordon-Cardo C, Pentlow K, Canete A, Finn R, Larson SM. Arbit E, et al. Among authors: cheung nk. Eur J Nucl Med. 1995 May;22(5):419-26. doi: 10.1007/BF00839056. Eur J Nucl Med. 1995. PMID: 7641750

5

Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta doses.

Ugur O, Kostakoglu L, Hui ET, Fisher DR, Garmestani K, Gansow OA, Cheung NK, Larson SM. Ugur O, et al. Among authors: cheung nk. Nucl Med Biol. 1996 Jan;23(1):1-8. doi: 10.1016/0969-8051(95)02001-2. Nucl Med Biol. 1996. PMID: 9004907

6

Current status of radioimmunotherapy.

Larson SM, Divgi CR, Scott A, Sgouros G, Graham MC, Kostakoglu L, Scheinberg D, Cheung NK, Schlom J, Finn RD. Larson SM, et al. Among authors: cheung nk. Nucl Med Biol. 1994 Jul;21(5):785-92. doi: 10.1016/0969-8051(94)90050-7. Nucl Med Biol. 1994. PMID: 9241655

7

3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.

Cheung NK, Kushner BH, Yeh SD, Larson SM. Cheung NK, et al. Int J Oncol. 1998 Jun;12(6):1299-306. doi: 10.3892/ijo.12.6.1299. Int J Oncol. 1998. PMID: 9592190 Clinical Trial.

8

Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy.

Pentlow KS, Graham MC, Lambrecht RM, Cheung NK, Larson SM. Pentlow KS, et al. Among authors: cheung nk. Med Phys. 1991 May-Jun;18(3):357-66. doi: 10.1118/1.596728. Med Phys. 1991. PMID: 1870476

9

99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors.

Fonti R, Cheung NK, Bridger GJ, Guo HF, Abrams MJ, Larson SM. Fonti R, et al. Among authors: cheung nk. Nucl Med Biol. 1999 Aug;26(6):681-6. doi: 10.1016/s0969-8051(99)00026-8. Nucl Med Biol. 1999. PMID: 10587107

10

Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9.

Modak S, Guo HF, Humm JL, Smith-Jones PM, Larson SM, Cheung NK. Modak S, et al. Among authors: cheung nk. Cancer Biother Radiopharm. 2005 Oct;20(5):534-46. doi: 10.1089/cbr.2005.20.534. Cancer Biother Radiopharm. 2005. PMID: 16248769

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

503 results

Search Page